All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature.
Forghieri F, Bigliardi S, Quadrelli C, Morselli M, Potenza L, Paolini A, Colaci E, Barozzi P, Zucchini P, Riva G, Vallerini D, Lagreca I, Marasca R, Narni F, Venditti A, Martelli MP, Falini B, Lo Coco F, Amadori S, Luppi M.
Forghieri F, et al. Among authors: barozzi p.
Clin Case Rep. 2016 Oct 24;4(12):1138-1146. doi: 10.1002/ccr3.723. eCollection 2016 Dec.
Clin Case Rep. 2016.
PMID: 27980750
Free PMC article.